ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 288

$625K Total Retail Price of All Prescriptions

Rank: 6 out of 288

321 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

20% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,181 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 458 396 1 1
DIVALPROEX SODIUM 376 354 2 32
OMEPRAZOLE 336 272 3 4
HYDROCODONE-ACETAMINOPHEN 323 239 S3 4 3
LEVOTHYROXINE SODIUM 268 221 5 2
PRAVASTATIN SODIUM 246 200 6 22
CITALOPRAM HBR 229 211 7 12
METFORMIN HCL 222 180 8 6
POTASSIUM CHLORIDE 197 170 9 18
DONEPEZIL HCL 186 186 10 29
MORPHINE SULFATE ER 180 76 S2 11 25
FUROSEMIDE 171 148 12 8
LAMOTRIGINE 164 106 13 64
HYDROCHLOROTHIAZIDE 163 152 14 9
AMLODIPINE BESYLATE 163 156 14 7
METOPROLOL SUCCINATE 152 132 16 20
NAMENDA 149 149 17 30
ZOLPIDEM TARTRATE 140 91 18 24
POLYETHYLENE GLYCOL 3350 133 112 19 48
METOPROLOL TARTRATE 128 122 20 15
QUETIAPINE FUMARATE 113 95 21 42
FLUOXETINE HCL 110 109 22 36
ALENDRONATE SODIUM 101 99 23 34
VOLTAREN 98 78 24 140
CRESTOR 96 77 25 46
WARFARIN SODIUM 95 88 26 11
CARVEDILOL 94 93 27 27
LANTUS 93 74 28 47
FENTANYL 91 32 S2 29 49
TRAZODONE HCL 88 71 30 13
ATORVASTATIN CALCIUM 88 62 30 21
JANUVIA 88 61 30 107
SIMVASTATIN 87 75 33 5
ESCITALOPRAM OXALATE 87 76 33 61
TRAMADOL HCL 82 61 35 31
MELOXICAM 76 63 36 37
LOSARTAN POTASSIUM 75 72 37 19
LEVETIRACETAM 69 43 38 89
SERTRALINE HCL 68 55 39 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 65 40 55
CYMBALTA 65 54 40 28
KLOR-CON M20 62 59 42 88
GABAPENTIN 62 58 42 10
HYDRALAZINE HCL 62 53 42 162
ADVAIR DISKUS 61 54 45 38
LOVASTATIN 57 57 46 14
SEROQUEL XR 56 34 47 176
FLUTICASONE PROPIONATE 55 48 48 57
RANITIDINE HCL 55 45 48 35
BACLOFEN 54 19 50 54
METHADONE HCL 53 41 S2 51 39
METHOCARBAMOL 53 0 R 51 126
RISPERIDONE 52 33 53 40
SPIRONOLACTONE 51 34 54 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.